Compare · AGL vs DVA
AGL vs DVA
Side-by-side comparison of agilon health inc. (AGL) and DaVita Inc. (DVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AGL and DVA operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- DVA is the larger of the two at $12.34B, about 7.6x AGL ($1.62B).
- Over the past year, AGL is up 69.8% and DVA is up 38.5% - AGL leads by 31.3 points.
- DVA has been more active in the news (11 items in the past 4 weeks vs 10 for AGL).
- AGL has more recent analyst coverage (25 ratings vs 13 for DVA).
- Company
- agilon health inc.
- DaVita Inc.
- Price
- $97.02+0.74%
- $190.72-0.74%
- Market cap
- $1.62B
- $12.34B
- 1M return
- +60.39%
- -2.76%
- 1Y return
- +69.82%
- +38.48%
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NYSE
- IPO
- 2021
- News (4w)
- 10
- 11
- Recent ratings
- 25
- 13
agilon health inc.
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Long Beach, California.
DaVita Inc.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services; vascular access services; clinical research programs; physician services; and comprehensive care services. As of December 31, 2020, it provided dialysis and administrative services in the United States through a network of 2,816 outpatient dialysis centers serving approximately 204,200 patients; and operated 321 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 36,700 patients. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Latest AGL
- Chief Legal Officer Zamore Denise covered exercise/tax liability with 485 shares, decreasing direct ownership by 0.73% to 66,112 units (SEC Form 4) (tax liability)
- Director Wulf John William was granted 2,133 shares, increasing direct ownership by 15% to 16,765 units (SEC Form 4)
- Director Williams Ronald A was granted 2,133 shares, increasing direct ownership by 1% to 149,141 units (SEC Form 4)
- Director Mcloughlin Karen was granted 2,133 shares, increasing direct ownership by 35% to 8,207 units (SEC Form 4)
- Director Mckenzie Diana was granted 2,133 shares, increasing direct ownership by 39% to 7,633 units (SEC Form 4)
- Director Mansukani Sharad was granted 2,133 shares, increasing direct ownership by 4% to 56,242 units (SEC Form 4)
- Director Battaglia Silvana was granted 2,133 shares, increasing direct ownership by 37% to 7,926 units (SEC Form 4)
- agilon health inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Chief Accounting Officer Gertsch Timothy covered exercise/tax liability with 8 shares, decreasing direct ownership by 0.06% to 14,169 units (SEC Form 4) (for withholding tax)
- agilon health upgraded by Barclays with a new price target
Latest DVA
- Director Yale Phyllis R gifted 5,038 shares, decreasing direct ownership by 35% to 9,525 units (SEC Form 4)
- Director Pullin Dennis W was granted 250 shares, increasing direct ownership by 10% to 2,671 units (SEC Form 4)
- Director Schoppert Wendy Lee was granted 250 shares (SEC Form 4)
- Director Moore Gregory J. was granted 250 shares, increasing direct ownership by 3% to 7,813 units (SEC Form 4)
- Director Arway Pamela M was granted 250 shares, increasing direct ownership by 0.94% to 26,945 units (SEC Form 4)
- Director Yale Phyllis R was granted 250 shares, increasing direct ownership by 2% to 14,563 units (SEC Form 4)
- Director Hollar Jason M. was granted 250 shares, increasing direct ownership by 4% to 6,605 units (SEC Form 4)
- Director Desoer Barbara J was granted 250 shares (SEC Form 4)
- Director Schechter Adam H was granted 250 shares, increasing direct ownership by 5% to 5,692 units (SEC Form 4)
- Chief Compliance Officer Hearty James O exercised 5,784 shares at a strike of $110.63, returned $640,061 worth of shares to the company (3,231 units at $198.10), covered exercise/tax liability with 1,117 shares and sold $2,909,745 worth of shares (15,000 units at $193.98), decreasing direct ownership by 38% to 22,389 units (SEC Form 4) to satisfy withholding obligation